The REPOSI (REgistro POliterapie SIMI) study is a collaborative and indipendent study of the Italian Society of Internal Medicine (SIMI) and the Mario Negri Institute of Pharmacological Research. We analyzed clinical adverse events (AE) during hospital stay. Among 66 Italian internal and geriatric medicine hospital wards, 1,267 in-patients were enrolled. 412 patients (32.5%) experienced at least one AE and 19 of them died as a consequence of an AE. Independent predictors of AEs were: previous admissions to hospital in the past 3 months; bladder catheter; proton-pump inhibitor; immunosuppressant therapy
The REPOSI study / S. Damanti, P. Dionigi Rossi, D. Mari. ((Intervento presentato al 9. convegno EFIM Clinical research seminar tenutosi a Paris nel 2013.
The REPOSI study
S. DamantiConceptualization
;D. MariSupervision
2013-07
Abstract
The REPOSI (REgistro POliterapie SIMI) study is a collaborative and indipendent study of the Italian Society of Internal Medicine (SIMI) and the Mario Negri Institute of Pharmacological Research. We analyzed clinical adverse events (AE) during hospital stay. Among 66 Italian internal and geriatric medicine hospital wards, 1,267 in-patients were enrolled. 412 patients (32.5%) experienced at least one AE and 19 of them died as a consequence of an AE. Independent predictors of AEs were: previous admissions to hospital in the past 3 months; bladder catheter; proton-pump inhibitor; immunosuppressant therapy
| File | Dimensione | Formato | |
|---|---|---|---|
|
The REPOSI Study DAMANTI.pdf
accesso aperto
Tipologia:
Altro
Dimensione
462.94 kB
Formato
Adobe PDF
|
462.94 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
